French Observational study on patients’ Characteristics, Utilization and Survival outcomes in Gilteritinib-treated patients (FOCUS)

26/05/2025
09/01/2026
EU PAS number:
EUPAS1000000597
Study
Cancelled
Documents
Study protocol
Study results
Study report
Other information